Cancer Immunology Immunotherapy
Radiotherapy drives PD-1 expression on monocytes to attenuate anti-tumor immunity
By Jiandong Zhang, Chen Chen, Qiuyu Mu and 2 others.
Abstract
Radiotherapy is a cornerstone of cancer treatment, but resistance in solid tumors frequently leads to treatment failure. The mechanisms underlying radiotherapy-induced resistance, particularly its immunomodulatory effects, remain unclear. This study demonstrates that radiotherapy upregulates PD-1 expression on tumor-associated monocytes via the adenosine-A2AR-cAMP-PKA-NF-κB pathway. These PD-1 + monocytes suppress the anti-tumor activity of CD8 + T cells. Targeting this subset enhanced radiotherapy efficacy. Notably, tissues from radiotherapy-resistant patients showed elevated infiltration of PD-1 + monocytes. Thus, we identify a distinct immunosuppressive monocyte subset that accumulates post-radiotherapy. Its depletion represents a promising strategy to overcome resistance and boost anti-tumor immunity.
Keywords
- Cancer Immunotherapy and Biomarkers
- Open access
Source
Published in Cancer Immunology Immunotherapy. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.